Evonik

Leading Beyond Chemistry

Company Presentation Q2 2021

Key messages Q2 2021

Strong Q2 and sustained positive dynamic into H2 driving outlook uplift

Strong Q2 performance with adj. EBITDA of €649 m clearly above pre-pandemic level (+15% vs Q2 2019)

"Specialty growth": Growth divisions with 18% higher adj. EBITDA vs. Q2 2019

Structural growth drivers well intact across all three growth divisions - sustainability as common theme

Continued strong cash generation: On track to extend 40% cash conversion track record also in FY 2021

Sustained positive dynamic into H2 - raw material price impact balancing out across the portfolio

FY 2021 adj. EBITDA outlook raised to €2.3 to 2.4 bn - likely ending up in upper part of range

2 | August / September 2021 | Evonik Q2 2021 Company Presentation

Table of contents

  1. Evonik at a glance
  2. Strategy
  3. Financials Q2 2021
  4. Appendix

3 | August / September 2021 | Evonik Q2 2021 Company Presentation

LEADING BEYOND CHEMISTRY

TO IMPROVE LIFE, TODAY AND TOMORROW

4 | August / September 2021 | Evonik Q2 2021 Company Presentation

Leading Beyond Chemistry - Our purpose

Evonik on the way to become a best-in-class specialty chemicals company

Video "We are Evonik"

Leading …

… Beyond …

… Chemistry

  • Leading market positions in 80% of our business
  • Leading key financial indicators
  • Connecting skills and perspectives
  • Develop solutions together with partners
  • Sustainability key driver of growth
  • Clear focus on specialty chemicals
  • Target 100% specialty portfolio

5 | August / September 2021 | Evonik Q2 2021 Company Presentation

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Evonik Industries AG published this content on 16 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 October 2021 06:45:03 UTC.